Osaic Holdings’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Osaic Holdings's MXCT Position: Q2 2026 in Review
Osaic Holdings held its MaxCyte (MXCT) position steady in Q2 2026 at 470 shares worth $578. The position accounts for ﹤0.01% of the portfolio, ranked #7620.
Osaic Holdings first reported a position in MXCT in Q4 2021 and has held it in 17 quarters since. The position peaked at $21.1K in Q4 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Osaic Holdings held 470 shares of MaxCyte worth $578 as of Q2 2026.
- Osaic Holdings left its MaxCyte share count unchanged in Q2 2026.
- MaxCyte made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7620 holding.
- Osaic Holdings first reported a position in MaxCyte in Q4 2021 and has held it in 17 quarters since.
- Osaic Holdings's MaxCyte position peaked at $21.1K in Q4 2023.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.